Issues
-
Cover image
Cover Image
Cover: High HDAC9 expression is associated with B cell malignancies and the article by Gil et al. on page 1483 suggests that deregulation of this epigenetic modifier can promote lymphoproliferative disease and lymphoma. Impaired p53 tumor suppressor activity in this mouse model is thought to be an important factor in disease development. Immunofluorescence analysis of spleen sections using antibodies against total p53 (top left, green) and acetylated p53 (top right, green) in wild-type control mice compared with total p53 (bottom left, green) and acetylated p53 (bottom right, green) in mice expressing transgenic histone deacetylase 9 (HDAC9) in the B cell lineage. Both wild-type endogenous and transgenic HDAC9 are stained red. Image provided by Louise Howell and licenced under a Creative Commons Attribution 4.0 International licence.
- PDF Icon PDF LinkTable of contents
- PDF Icon PDF LinkIssue info
REVIEW
Renal disease pathophysiology and treatment: contributions from the rat
Summary: This Review highlights the key role that the rat continues to play in improving our understanding of the etiologies of renal pathologies, and how these insights have opened up new therapeutic avenues.
RESEARCH ARTICLES
Heterotypic mouse models of canine osteosarcoma recapitulate tumor heterogeneity and biological behavior
Editors' choice: We developed a system that recapitulates the heterogeneous biological behavior of bone cancer in mouse models and describe novel methods to study tumor–stromal interactions in these models.
Whole-genome sequence, SNP chips and pedigree structure: building demographic profiles in domestic dog breeds to optimize genetic-trait mapping
Summary: Successful application of whole-genome sequencing and genome-wide association studies for identifying both loci and mutations in canines is influenced by breed structure and demography, motivating researchers to generate breed-specific strategies for canine genetic studies.
Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models
Summary: Lurbinectedin-gemcitabine synergism in PDA models involves lurbinectedin-induced tumor macrophage depletion, triggering CDA downregulation and enhanced DNA damage, supporting the use of this combination to treat macrophage-infiltrated pancreatic tumors.
Helicobacter pylori VacA, acting through receptor protein tyrosine phosphatase α, is crucial for CagA phosphorylation in human duodenum carcinoma cell line AZ-521
Summary: The authors show a newly identified role of VacA in Helicobacter pylori infection through induction of tyrosine phosphorylation of CagA acting through the VacA receptor RPTPα.
Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice
Summary: This study demonstrates that aberrant expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma through altering expression of genes involved in the cell cycle and survival, and modulating the activity of key B-lineage factors such as BCL6 and p53.
Microglia activation in a pediatric rabbit model of tuberculous meningitis
Summary: A clinically relevant novel rabbit model provides robust microglial activation and neurological deficits as seen in children with pediatric central nervous system tuberculosis.
Recovery of erectile function comparing autologous nerve grafts, unseeded conduits, Schwann-cell-seeded guidance tubes and GDNF-overexpressing Schwann cell grafts
Summary: Schwann-cell-seeded scaffolds and GDNF-overexpressing Schwann cell grafts are superior to unseeded tubes and autologous nerve grafts for the repair of erectile nerve gaps following nerve excision in rats.
RETRACTION
Call for Papers – Infectious Disease: Evolution, Mechanisms and Global Health
Showcase your latest research on our upcoming Special Issue: Infectious Disease: Evolution, Mechanisms and Global Health. This issue will be coordinated by DMM Editors Sumana Sanyal and David Tobin alongside Guest Editors Judi Allen and Russell Vance. The deadline for submitting articles to this Special Issue is Monday 20 January 2025.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate a DMM programme on antimicrobial resistance on 26 March 2025. Find out more and register to join us in March 2025 in Liverpool, UK.
New Special Issue: Translating Multiscale Research in Rare Disease. Edited by Monica Justice, Monkol Lek, Karen Liu and Kate Rauen.
This special issue features original Research, Resources & Methods and Review-type articles that aim to interrogate the mechanisms of rare diseases to foster meaningful clinical progress in their diagnosis and treatment.
Subject collection: Building advocacy into research
DMM’s series - Building advocacy into research - features interviews, ‘The Patient’s Voice’, with patients and advocates for a range of disease types, with the aim of supporting the highest quality research for the benefit of all patients affected by disease.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.